Detalhe da pesquisa
1.
Intratumoral Immunotherapy: Is It Ready for Prime Time?
Curr Oncol Rep
; 25(8): 857-867, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129706
2.
Evaluation of supportive care needs, sexuality and quality of life in phase 1 trials: a prospective monocentric study.
Support Care Cancer
; 30(12): 9841-9849, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36271944
3.
Understanding genetic determinants of resistance to immune checkpoint blockers.
Semin Cancer Biol
; 65: 123-139, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31881338
4.
Patterns of progression in patients treated for immuno-oncology antibodies combination.
Cancer Immunol Immunother
; 70(1): 221-232, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700090
5.
Managing Hyperprogressive Disease in the Era of Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade: A Case Discussion and Review of the Literature.
Oncologist
; 25(5): 369-374, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32091646
6.
[Management of adverse events associated with cancer immunotherapy]. / Prise en charge des effets indésirables de l'immunothérapie des cancers.
Rev Prat
; 69(1): 39-48, 2019 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-30983283
7.
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Lancet Oncol
; 19(9): 1180-1191, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30120041
8.
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
J Hepatol
; 68(6): 1181-1190, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29427729
9.
[Cardiac and vascular toxicity of chemotherapies]. / Toxicité cardiaque et vasculaire des chimiothérapies.
Rev Prat
; 68(3): 326-329, 2018 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-30869300
10.
Myocarditis with Immune Checkpoint Blockade.
N Engl J Med
; 376(3): 290-1, 2017 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28102662
11.
Immune checkpoint inhibitors in advanced nonsmall cell lung cancer.
Curr Opin Oncol
; 27(2): 108-17, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25602683
12.
Reply to: "Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?"
J Hepatol
; 70(3): 566-567, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30527952
13.
T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques.
J Virol
; 87(11): 6073-80, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23536679
14.
Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1.
Ann Rheum Dis
; 78(7): e67, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29858173
15.
Ocular surface toxicities associated with modern anticancer therapies.
Surv Ophthalmol
; 69(2): 198-210, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806566
16.
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors.
J Immunother Cancer
; 12(5)2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702147
17.
Antibody drug conjugates in older patients: State of the art.
Crit Rev Oncol Hematol
; 193: 104212, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007063
18.
Phase II study to determine the anti-tumor activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in esophageal cancer.
Clin Cancer Res
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709220
19.
Reply to: "Incidence of grade 3-4 liver injury under immune checkpoints inhibitors: A retrospective study".
J Hepatol
; 69(6): 1397-1398, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30297274
20.
Reply to: "Mortality due to immunotherapy related hepatitis".
J Hepatol
; 69(4): 978-979, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30097327